Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2023 Earnings Call Transcript August 2, 2023
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.89.
Operator: Good afternoon and welcome to the Sarepta Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today’s program is being...
